Lysine (symbol Lys or K) is an α-amino acid that is used in the biosynthesis of proteins. It contains an α-amino group (which is in the protonated −NH3+ form under biological conditions), an α-carboxylic acid group (which is in the deprotonated −COO− form under biological conditions), and a side chain lysyl ((CH2)4NH2), classifying it as a basic, charged (at physiological pH), aliphatic amino acid. It is encoded by the codons, AAA and AAG. Like almost all other amino acids, the α-carbon is chiral and lysine may refer to either enantiomer or a racemic mixture of both. For the purpose of this article, lysine will refer to the biologically active enantiomer L-lysine, where the α-carbon is in the S configuration.
Lysine plays several roles in humans, most importantly proteinogenesis, but also in the crosslinking of collagen polypeptides, uptake of essential mineral nutrients, and in the production of carnitine, which is key in fatty acid metabolism. Lysine is also often involved in histone modifications, and thus, impacts the epigenome. The ε-amino group often participates in hydrogen bonding and as a general base in catalysis. The ε-ammonium group (NH3+) is attached to the fourth carbon from the α-carbon, which is attached to the carboxyl (C=OOH) group.
Due to its importance in several biological processes, a lack of lysine can lead to several disease states including defective connective tissues, impaired fatty acid metabolism, anaemia, and systemic protein-energy deficiency. In contrast, an overabundance of lysine, caused by ineffective catabolism, can cause severe neurological issues.
Lysine was first isolated by the German biological chemist Ferdinand Heinrich Edmund Drechsel in 1889 from the protein casein in milk. He named it "lysin". In 1902, the German chemists Emil Fischer and Fritz Weigert determined lysine's chemical structure by synthesizing it.
The DAP pathway is found in both prokaryotes and plants and begins with the dihydrodipicolinate synthase (DHDPS) (E.C 220.127.116.11) catalysedcondensation reaction between the aspartate derived, L-aspartate semialdehyde, and pyruvate to form (4S)-4-hydroxy-2,3,4,5-tetrahydro-(2S)-dipicolinic acid (HTPA). The product is then reduced by dihydrodipicolinate reductase (DHDPR) (E.C 18.104.22.168), with NAD(P)H as a proton donor, to yield 2,3,4,5-tetrahydrodipicolinate (THDP). From this point on, there are four pathway variations found in different species, namely the acetylase, aminotransferase, dehydrogenase, and succinylase pathways. Both the acetylase and succinylase variant pathways use four enzyme catalysed steps, the aminotransferase pathway uses two enzymes, and the dehydrogenase pathway uses a single enzyme. These four variant pathways converge at the formation of the penultimate product, meso‑diaminopimelate, which is subsequently enzymatically decarboxylated in an irreversible reaction catalysed by diaminopimelate decarboxylase (DAPDC) (E.C 22.214.171.124) to produce L-lysine. The DAP pathway is regulated at multiple levels, including upstream at the enzymes involved in aspartate processing as well as at the initial DHDPS catalysed condensation step. Lysine imparts a strong negative feedback loop on these enzymes and, subsequently, regulates the entire pathway.
Saccharopine lysine catabolism pathway. The saccharopine pathway is the most prominent pathway for the catabolism of lysine.
Like all amino acids, catabolism of lysine is initiated from the uptake of dietary lysine or from the breakdown of intracellular protein. Catabolism is also used as a means to control the intracellular concentration of free lysine and maintain a steady-state to prevent the toxic effects of excessive free lysine. There are several pathways involved in lysine catabolism but the most commonly used is the saccharopine pathway, which primarily takes place in the liver (and equivalent organs) in animals, specifically within the mitochondria. This is the reverse of the previously described AAA pathway. In animals and plants, the first two steps of the saccharopine pathway are catalysed by the bifunctional enzyme, α-aminoadipic semialdehyde synthase (AASS), which possess both lysine-ketoglutarate reductase (LKR) (E.C 126.96.36.199) and SDH activities, whereas in other organisms, such as bacteria and fungi, both of these enzymes are encoded by separate genes. The first step involves the LKR catalysed reduction of L-lysine in the presence of α-ketoglutarate to produce saccharopine, with NAD(P)H acting as a proton donor. Saccharopine then undergoes a dehydration reaction, catalysed by SDH in the presence of NAD+, to produce AAS and glutamate.AAS dehydrogenase (AASD) (E.C 188.8.131.52) then further dehydrates the molecule into AAA. Subsequently, PLP-AT catalyses the reverse reaction to that of the AAA biosynthesis pathway, resulting in AAA being converted to α-ketoadipate. The product, α‑ketoadipate, is decarboxylated in the presence of NAD+ and coenzyme A to yield glutaryl-CoA, however the enzyme involved in this is yet to be fully elucidated. Some evidence suggests that the 2-oxoadipate dehydrogenase complex (OADHc), which is structurally homologous to the E1 subunit of the oxoglutarate dehydrogenase complex (OGDHc) (E.C 184.108.40.206), is responsible for the decarboxylation reaction. Finally, glutaryl-CoA is oxidatively decarboxylated to crotony-CoA by glutaryl-CoA dehydrogenase (E.C 220.127.116.11), which goes on to be further processed through multiple enzymatic steps to yield acetyl-CoA; an essential carbon metabolite involved in the tricarboxylic acid cycle (TCA).
Lysine is one of the nine essential amino acids in humans. The human nutritional requirements varies from ~60 mg·kg−1·d−1 in infancy to ~30 mg·kg−1·d−1 in adults. This requirement is commonly met in a western society with the intake of lysine from meat and vegetable sources well in excess of the recommended requirement. In vegetarian diets, the intake of lysine is less due to the limiting quantity of lysine in cereal crops compared to meat sources. Given the limiting concentration of lysine in cereal crops, it has long been speculated that the content of lysine can be increased through genetic modification practices. Often these practices have involved the intentional dysregulation of the DAP pathway by means of introducing lysine feedback-insensitive orthologues of the DHDPS enzyme. These methods have met limited success likely due to the toxic side effects of increased free lysine and indirect effects on the TCA cycle. Plants accumulate lysine and other amino acids in the form of seed storage proteins, found within the seeds of the plant, and this represents the edible component of cereal crops. This highlights the need to not only increase free lysine, but also direct lysine towards the synthesis of stable seed storage proteins, and subsequently, increase the nutritional value of the consumable component of crops. Whilst genetic modification practices have met limited success, more traditional selective breeding techniques have allowed for the isolation of "Quality Protein Maize", which has significantly increased levels of lysine and tryptophan, also an essential amino acid. This increase in lysine content is attributed to an opaque-2 mutation that reduced the transcription of lysine lacking zein related seed storage proteins and, as a result, increased the abundance of other proteins that are rich in lysine. Commonly, to overcome the limiting abundance of lysine in livestock feed, industrially produced lysine is added. The industrial process includes the fermentative culturing of Corynebacterium glutamicum and the subsequent purification of lysine.
Good sources of lysine are high-protein foods such as eggs, meat (specifically red meat, lamb, pork, and poultry), soy, beans and peas, cheese (particularly Parmesan), and certain fish (such as cod and sardines). Lysine is the limiting amino acid (the essential amino acid found in the smallest quantity in the particular foodstuff) in most cereal grains, but is plentiful in most pulses (legumes). A vegetarian or low animal protein diet can be adequate for protein, including lysine, if it includes both cereal grains and legumes, but there is no need for the two food groups to be consumed in the same meals.
A food is considered to have sufficient lysine if it has at least 51 mg of lysine per gram of protein (so that the protein is 5.1% lysine). L-lysine HCl is used as a dietary supplement, providing 80.03% L-lysine. As such, 1 g of L-lysine is contained in 1.25 g of L-lysine HCl.
Example foods containing significant proportions of lysine
The most common role for lysine is proteinogenesis. Lysine frequently plays an important role in protein structure. Since its side chain contains a positively charged group on one end and a long hydrophobic carbon tail close to the backbone, lysine is considered somewhat amphipathic. For this reason, lysine can be found buried as well as more commonly in solvent channels and on the exterior of proteins, where it can interact with the aqueous environment. Lysine can also contribute to protein stability as its ε-amino group often participates in hydrogen bonding, salt bridges and covalent interactions to form a Schiff base.
Lysine has also been implicated to play a key role in other biological processes including; structural proteins of connective tissues, calciumhomeostasis, and fatty acidmetabolism. Lysine has been shown to be involved in the crosslinking between the three helical polypeptides in collagen, resulting in its stability and tensile strength. This mechanism is akin to the role of lysine in bacterial cell walls, in which lysine (and meso-diaminopimelate) are critical to the formation of crosslinks, and therefore, stability of the cell wall. This concept has previously been explored as a means to circumvent the unwanted release of potentially pathogenic genetically modified bacteria. It was proposed that an auxotrophic strain of Escherichia coli (X1776) could be used for all genetic modification practices, as the strain is unable to survive without the supplementation of DAP, and thus, cannot live outside of a laboratory environment. Lysine has also been proposed to be involved in calcium intestinal absorption and renal retention, and thus, may play a role in calcium homeostasis. Finally, lysine has been shown to be a precursor for carnitine, which transports fatty acids to the mitochondria, where they can be oxidised for the release of energy. Carnitine is synthesised from trimethyllysine, which is a product of the degradation of certain proteins, as such lysine must first be incorporated into proteins and be methylated prior to being converted to carnitine. However, in mammals the primary source of carnitine is through dietary sources, rather than through lysine conversion.
There has been a long discussion that lysine, when administered intravenously or orally, can significantly increase the release of growth hormones. This has led to athletes using lysine as a means of promoting muscle growth while training, however, no significant evidence to support this application of lysine has been found to date.
Because herpes simplex virus (HSV) proteins are richer in arginine and poorer in lysine than the cells they infect, lysine supplements have been tried as a treatment. Since the two amino acids are taken up in the intestine, reclaimed in the kidney, and moved into cells by the same amino acid transporters, an abundance of lysine would, in theory, limit the amount of arginine available for viral replication. Clinical studies do not provide good evidence for effectiveness as a prophylactic or in the treatment for HSV outbreaks. In response to product claims that lysine could improve immune responses the HSV, a review by the European Food Safety Authority found no evidence of a cause-effect relationship. The same review, published in 2011, found no evidence to support claims that lysine could lower cholesterol, increase appetite, contribute to protein synthesis in any role other than as an ordinary nutrient, or increase calcium absorption or retention.
Roles in disease
Diseases related to lysine are a result of the downstream processing of lysine, i.e. the incorporation into proteins or modification into alternative biomolecules. The role of lysine in collagen has been outlined above, however, a lack of lysine and hydroxylysine involved in the crosslinking of collagen peptides has been linked to a disease state of the connective tissue. As carnitine is a key lysine-derived metabolite involved in fatty acid metabolism, a substandard diet lacking sufficient carnitine and lysine can lead to decreased carnitine levels, which can have significant cascading effects on an individual’s health. Lysine has also been shown to play a role in anaemia, as lysine is suspected to have an effect on the uptake of iron and, subsequently, the concentration of ferritin in blood plasma. However, the exact mechanism of action is yet to be elucidated. Most commonly, lysine deficiency is seen in non-western societies and manifests as protein-energy malnutrition, which has profound and systemic effects on the health of the individual. There is also a hereditary genetic disease that involves mutations in the enzymes responsible for lysine catabolism, namely the bifunctional AASS enzyme of the saccharopine pathway. Due to a lack of lysine catabolism, the amino acid accumulates in plasma and patients develop hyperlysinaemia, which can present as asymptomatic to severe neurological disabilities, including epilepsy, ataxia, spasticity, and psychomotor impairment. It must be noted however, that the clinical significance of hyperlysinemia is the subject of debate in the field with some studies finding no correlation between physical or mental disabilities and hyperlysinemia. In addition to this, mutations in genes related to lysine metabolism have been implicated in several disease states, including pyridoxine-dependent epilepsia (ALDH7A1 gene), α-ketoadipic and α-aminoadipic aciduria (DHTKD1 gene), and glutaric aciduria type 1 (GCDH gene).
Hyperlysinuria is marked by high amounts of lysine in the urine. It is often due to a metabolic disease in which a protein involved in the breakdown of lysine is non functional due to a genetic mutation. It may also occur due to a failure of renal tubular transport.
Use of lysine in animal feed
Lysine production for animal feed is a major global industry, reaching in 2009 almost 700,000 tonnes for a market value of over €1.22 billion. Lysine is an important additive to animal feed because it is a limiting amino acid when optimizing the growth of certain animals such as pigs and chickens for the production of meat. Lysine supplementation allows for the use of lower-cost plant protein (maize, for instance, rather than soy) while maintaining high growth rates, and limiting the pollution from nitrogen excretion. In turn, however, phosphate pollution is a major environmental cost when corn is used as feed for poultry and swine.
Lysine is industrially produced by microbial fermentation, from a base mainly of sugar. Genetic engineering research is actively pursuing bacterial strains to improve the efficiency of production and allow lysine to be made from other substrates.
In 1996, lysine became the focus of a price-fixing case, the largest in United States history. The Archer Daniels Midland Company paid a fine of US$100 million, and three of its executives were convicted and served prison time. Also found guilty in the price-fixing case were two Japanese firms (Ajinomoto, Kyowa Hakko) and a South Korean firm (Sewon). Secret video recordings of the conspirators fixing lysine's price can be found online or by requesting the video from the U.S. Department of Justice, Antitrust Division. This case served as the basis of the movie The Informant!, and a book of the same title.
^Lysine. The Biology Project, Department of Biochemistry and Molecular Biophysics, University of Arizona.
^Drechsel E (1889). "Zur Kenntniss der Spaltungsprodukte des Caseïns" [[Contribution] to [our] knowledge of the cleavage products of casein]. Journal für Praktische Chemie. 2nd series (in German). 39: 425–429. doi:10.1002/prac.18890390135. On p. 428, Drechsel presented an empirical formula for the chloroplatinate salt of lysine – C8H16N2O2Cl2•PtCl4 + H2O – but he later admitted that this formula was wrong because the salt's crystals contained ethanol instead of water. See: Drechsel E (1891). "Der Abbau der Eiweissstoffe" [The disassembly of proteins]. Archiv für Anatomie und Physiologie (in German): 248–278.; Drechsel E. "Zur Kenntniss der Spaltungsproducte des Caseïns" [Contribution] to [our] knowledge of the cleavage products of casein] (in German): 254–260. From p. 256:] " … die darin enthaltene Base hat die Formel C6H14N2O2. Der anfängliche Irrthum ist dadurch veranlasst worden, dass das Chloroplatinat nicht, wie angenommen ward, Krystallwasser, sondern Krystallalkohol enthält, … " ( … the base [that's] contained therein has the [empirical] formula C6H14N2O2. The initial error was caused by the chloroplatinate containing not water in the crystal (as was assumed), but ethanol … )Cite journal requires |journal= (help)
^Drechsel E (1891). "Der Abbau der Eiweissstoffe" [The disassembly of proteins]. Archiv für Anatomie und Physiologie (in German): 248–278.; Fischer E (1891). "Ueber neue Spaltungsproducte des Leimes" [On new cleavage products of gelatin] (in German): 465–469. From p. 469:] " … die Base C6H14N2O2, welche mit dem Namen Lysin bezeichnet werden mag, … " ( … the base C6H14N2O2, which may be designated with the name "lysine", … ) [Note: Ernst Fischer was a graduate student of Drechsel.]Cite journal requires |journal= (help)
^ abHudson AO, Bless C, Macedo P, Chatterjee SP, Singh BK, Gilvarg C, Leustek T (January 2005). "Biosynthesis of lysine in plants: evidence for a variant of the known bacterial pathways". Biochimica et Biophysica Acta. 1721 (1–3): 27–36. doi:10.1016/j.bbagen.2004.09.008. PMID15652176.
^Soares da Costa TP, Muscroft-Taylor AC, Dobson RC, Devenish SR, Jameson GB, Gerrard JA (July 2010). "How essential is the 'essential' active-site lysine in dihydrodipicolinate synthase?". Biochimie. 92 (7): 837–45. doi:10.1016/j.biochi.2010.03.004. PMID20353808.
^Soares da Costa TP, Christensen JB, Desbois S, Gordon SE, Gupta R, Hogan CJ, Nelson TG, Downton MT, Gardhi CK, Abbott BM, Wagner J, Panjikar S, Perugini MA (2015). "Quaternary Structure Analyses of an Essential Oligomeric Enzyme". Analytical Ultracentrifugation. Methods in Enzymology. 562. pp. 205–23. doi:10.1016/bs.mie.2015.06.020. ISBN9780128029084. PMID26412653.
^Muscroft-Taylor AC, Soares da Costa TP, Gerrard JA (March 2010). "New insights into the mechanism of dihydrodipicolinate synthase using isothermal titration calorimetry". Biochimie. 92 (3): 254–62. doi:10.1016/j.biochi.2009.12.004. PMID20025926.
^Andi B, West AH, Cook PF (September 2004). "Kinetic mechanism of histidine-tagged homocitrate synthase from Saccharomyces cerevisiae". Biochemistry. 43 (37): 11790–5. doi:10.1021/bi048766p. PMID15362863.
^Bhattacharjee JK (1985). "alpha-Aminoadipate pathway for the biosynthesis of lysine in lower eukaryotes". Critical Reviews in Microbiology. 12 (2): 131–51. doi:10.3109/10408418509104427. PMID3928261.
^Bhattacharjee JK, Strassman M (May 1967). "Accumulation of tricarboxylic acids related to lysine biosynthesis in a yeast mutant". The Journal of Biological Chemistry. 242 (10): 2542–6. PMID6026248.
^Gaillardin CM, Ribet AM, Heslot H (November 1982). "Wild-type and mutant forms of homoisocitric dehydrogenase in the yeast Saccharomycopsis lipolytica". European Journal of Biochemistry. 128 (2–3): 489–94. doi:10.1111/j.1432-1033.1982.tb06991.x. PMID6759120.
^Kosuge T, Hoshino T (1999). "The alpha-aminoadipate pathway for lysine biosynthesis is widely distributed among Thermus strains". Journal of Bioscience and Bioengineering. 88 (6): 672–5. doi:10.1016/S1389-1723(00)87099-1. PMID16232683.
^ abcdNishida H, Nishiyama M, Kobashi N, Kosuge T, Hoshino T, Yamane H (December 1999). "A prokaryotic gene cluster involved in synthesis of lysine through the amino adipate pathway: a key to the evolution of amino acid biosynthesis". Genome Research. 9 (12): 1175–83. doi:10.1101/gr.9.12.1175. PMID10613839.
^ abcdNishida H, Nishiyama M (September 2000). "What is characteristic of fungal lysine synthesis through the alpha-aminoadipate pathway?". Journal of Molecular Evolution. 51 (3): 299–302. doi:10.1007/s002390010091. PMID11029074.
^Blemings KP, Crenshaw TD, Swick RW, Benevenga NJ (August 1994). "Lysine-alpha-ketoglutarate reductase and saccharopine dehydrogenase are located only in the mitochondrial matrix in rat liver". The Journal of Nutrition. 124 (8): 1215–21. doi:10.1093/jn/124.8.1215. PMID8064371.
^Galili G, Tang G, Zhu X, Gakiere B (June 2001). "Lysine catabolism: a stress and development super-regulated metabolic pathway". Current Opinion in Plant Biology. 4 (3): 261–6. doi:10.1016/s1369-5266(00)00170-9. PMID11312138.
^Zhu X, Tang G, Galili G (December 2002). "The activity of the Arabidopsis bifunctional lysine-ketoglutarate reductase/saccharopine dehydrogenase enzyme of lysine catabolism is regulated by functional interaction between its two enzyme domains". The Journal of Biological Chemistry. 277 (51): 49655–61. doi:10.1074/jbc.m205466200. PMID12393892.
^ abcKiyota E, Pena IA, Arruda P (November 2015). "The saccharopine pathway in seed development and stress response of maize". Plant, Cell & Environment. 38 (11): 2450–61. doi:10.1111/pce.12563. PMID25929294.
^Serrano GC, Rezende e Silva Figueira T, Kiyota E, Zanata N, Arruda P (March 2012). "Lysine degradation through the saccharopine pathway in bacteria: LKR and SDH in bacteria and its relationship to the plant and animal enzymes". FEBS Letters. 586 (6): 905–11. doi:10.1016/j.febslet.2012.02.023. PMID22449979.
^Sauer SW, Opp S, Hoffmann GF, Koeller DM, Okun JG, Kölker S (January 2011). "Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I". Brain. 134 (Pt 1): 157–70. doi:10.1093/brain/awq269. PMID20923787.
^Goh DL, Patel A, Thomas GH, Salomons GS, Schor DS, Jakobs C, Geraghty MT (July 2002). "Characterization of the human gene encoding alpha-aminoadipate aminotransferase (AADAT)". Molecular Genetics and Metabolism. 76 (3): 172–80. doi:10.1016/s1096-7192(02)00037-9. PMID12126930.
^Härtel U, Eckel E, Koch J, Fuchs G, Linder D, Buckel W (1 February 1993). "Purification of glutaryl-CoA dehydrogenase from Pseudomonas sp., an enzyme involved in the anaerobic degradation of benzoate". Archives of Microbiology. 159 (2): 174–81. doi:10.1007/bf00250279. PMID8439237.
^ abGalili G, Amir R (February 2013). "Fortifying plants with the essential amino acids lysine and methionine to improve nutritional quality". Plant Biotechnology Journal. 11 (2): 211–22. doi:10.1111/pbi.12025. PMID23279001.
^Angelovici R, Fait A, Fernie AR, Galili G (January 2011). "A seed high-lysine trait is negatively associated with the TCA cycle and slows down Arabidopsis seed germination". The New Phytologist. 189 (1): 148–59. doi:10.1111/j.1469-8137.2010.03478.x. PMID20946418.
^Corpas E, Blackman MR, Roberson R, Scholfield D, Harman SM (July 1993). "Oral arginine-lysine does not increase growth hormone or insulin-like growth factor-I in old men". Journal of Gerontology. 48 (4): M128–33. doi:10.1093/geronj/48.4.M128. PMID8315224.
^Gaby AR (2006). "Natural remedies for Herpes simplex". Altern Med Rev. 11 (2): 93–101. PMID16813459.
^Chi CC, Wang SH, Delamere FM, Wojnarowska F, Peters MC, Kanjirath PP (7 August 2015). "Interventions for prevention of herpes simplex labialis (cold sores on the lips)". The Cochrane Database of Systematic Reviews (8): CD010095. doi:10.1002/14651858.CD010095.pub2. PMID26252373.
^"Scientific Opinion on the substantiation of health claims related to L-lysine and immune defence against herpes virus (ID 453), maintenance of normal blood LDL-cholesterol concentrations (ID 454, 4669), increase in appetite leading to an increase in energ". EFSA Journal. 9 (4): 2063. 2011. doi:10.2903/j.efsa.2011.2063. ISSN1831-4732.
^Pinnell SR, Krane SM, Kenzora JE, Glimcher MJ (May 1972). "A heritable disorder of connective tissue. Hydroxylysine-deficient collagen disease". The New England Journal of Medicine. 286 (19): 1013–20. doi:10.1056/NEJM197205112861901. PMID5016372.
^Ghosh S, Smriga M, Vuvor F, Suri D, Mohammed H, Armah SM, Scrimshaw NS (October 2010). "Effect of lysine supplementation on health and morbidity in subjects belonging to poor peri-urban households in Accra, Ghana". The American Journal of Clinical Nutrition. 92 (4): 928–39. doi:10.3945/ajcn.2009.28834. PMID20720257.
^Hagen J, te Brinke H, Wanders RJ, Knegt AC, Oussoren E, Hoogeboom AJ, Ruijter GJ, Becker D, Schwab KO, Franke I, Duran M, Waterham HR, Sass JO, Houten SM (September 2015). "Genetic basis of alpha-aminoadipic and alpha-ketoadipic aciduria". Journal of Inherited Metabolic Disease. 38 (5): 873–9. doi:10.1007/s10545-015-9841-9. PMID25860818.